Showing results (71-80 of 6,751) with videos related to
Sort By:
Pageof 676
European Journal of Endocrinology|May 29, 2019
MANAGEMENT OF ENDOCRINE DISEASE: Predictive scores in autoimmune thyroid disease: are they useful?Grigoris EffraimidisEuropean Journal of Endocrinology|June 2, 2019
The brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney diseaseSusan Kralisch, Annett Hoffmann, Nora Klöting, et al.European Journal of Endocrinology|October 16, 2018
ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years laterHenry B Burch, David S CooperEuropean Journal of Endocrinology|October 16, 2018
Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?Marine Ollivier, Magalie Haissaguerre, Amandine Ferriere, et al.European Journal of Endocrinology|October 17, 2018
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDYMichael Buchfelder, Aart-Jan van der Lely, Beverly M K Biller, et al.European Journal of Endocrinology|October 17, 2018
Noonan syndrome males display Sertoli cell-specific primary testicular insufficiencySophie Moniez, Catherine Pienkowski, Benoit Lepage, et al.European Journal of Endocrinology|October 23, 1997
Effects of long-term total fasting and insulin on ob gene expression in obese patientsP H Andersen, K Kristensen, S B Pedersen, et al.European Journal of Endocrinology|October 23, 1997
The steroid antagonist RU486 given at pro-oestrus induces hypersecretion of follicle-stimulating hormone from oestrus afternoon to early metoestrus in the ratJ E Sánchez-Criado, M Tébar, A Ruiz, et al.European Journal of Endocrinology|April 16, 1998
Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failureM Sohmiya, K Ishikawa, Y KatoEuropean Journal of Endocrinology|April 16, 1998
Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expressionM W Elmlinger, M S Sanatani, M Bell, et al.Pageof 676